Clinical Trials
Novartis launches first-of-its-kind not-for-profit portfolio of medicines for symptomatic treatment of COVID-19
Novartis announced a new initiative to help patients in low-income and lower-middle-income countries (LIC; LMIC) access affordable medicines to treat the major symptoms of...
News
Thermo Fisher Scientific further strengthen its Global Response to COVID-19 to Support Development and Production of Therapeutics and Vaccines
Thermo Fisher Scientific, the world leader in serving science, continues to expand global capacity and capabilities across its leading pharma services network to support...
News
Synairgen Releases Positive Results from Breakthrough Coronavirus Treatment
Synairgen, the respiratory drug discovery and development company which originated from research at the University of Southampton, has released positive results from its clinical...
Press Releases
Vesigen Therapeutics launches with USD 28.5 million Series A investment led by Leaps by Bayer and Morningside Ventures
Vesigen Therapeutics launched with the objective to overcome the hurdle of targeted intracellular drug delivery of next-generation therapeutics, such as CRISPR-cas9, RNA molecules and...
Clinical Trials
Biogen Plans to Initiate Phase 4 Study Evaluating Benefit of SPINRAZA in Patients Treated with Zolgensma
Biogen Inc announced it plans to initiate a global Phase 4 clinical study, RESPOND, to examine the clinical benefit and assess the safety of...
Drug Research
Catalent Biologics to Invest $30 Million to Create European Clinical Manufacturing Center of Excellence in France
Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products,...
Drug Research
GSK and CureVac announce strategic mRNA technology collaboration
GlaxoSmithKline plc and CureVac announced the signing of a strategic collaboration agreement for the research, development, manufacturing and commercialisation of up to five mRNA-based...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read